Search Results 1121-1130 of 17871 for Assay
Some pathological processes, such as buildup of calcium in the arteries of the heart, occur in men and women even when other conventional risk factors and blood ...
... assay; 4. Failed or been intolerant of prior lines of systemic therapy; 5. Estimated life expectancy > 4 months; 6. At least 1 measurable lesion per RECIST ...
Known history of serum or plasma progranulin level less than one standard deviation below the normal participant mean for the laboratory performing the assay.
Known history of serum or plasma progranulin level less than one standard deviation below the normal patient mean for the laboratory performing the assay.
T-SPOT-TB assay OR has completed treatment for latent tuberculosis and has a negative chest x-ray. PPD or IGRA testing must occur within 52 weeks prior to ...
Patient must have BRAF V600E or BRAF V600K tumor genotype based on a Clinical Laboratory Improvement Act (CLIA) approved assay. Patient must have measurable ...
Serum free light chain (FLC) assay: Involved FLC level ≥ 10 mg/dl (≥ 100 mg/L) and an abnormal serum FLC ratio (< 0.26 or > 1.65). Subject has confirmed ...
Latent tuberculosis infection defined as positive interferon gamma release assay (IGRA), by QuantiFERON-TB Gold testing at Screening. History of clinically ...
Cohort 4 - Patients are required to have known tumor PD-\[L\]1 status determined by local testing using an approved assay. PD-\[L\]1 testing performed prior ...
Development and validation of a microRNA-based diagnostic assay for classification of renal cell carcinomas. Mol Oncol. 2013 Jun; 7(3):732-8. Epub 2013 Mar ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!